MedPath

lumicain

lumicain Topical Hemostatic Solution

Approved
Approval ID

9fdcce3e-e4d4-41ae-8609-37987c12414e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 23, 2020

Manufacturers
FDA

Medical Products Laboratories, Inc.

DUNS: 002290302

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Aluminium Chloride Hexahydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10733-412
Product Classification
G
Generic Name
Aluminium Chloride Hexahydrate
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 23, 2020
FDA Product Classification

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
ALUMINUM CHLORIDEActive
Quantity: 250 mg in 1 g
Code: 3CYT62D3GA
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

lumicain - FDA Drug Approval Details